Alena A. Gerasimova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alena A. Gerasimova has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Anna A. Vyazovaya
St. Petersburg Pasteur Institute
5 shared publications - Igor Mokrousov
Laboratory of Molecular Epidemiology and Evolutionary Genetics St. Petersburg Pasteur Institute St. Petersburg Russia
5 shared publications - Natalya S. Solovieva
St. Petersburg Research Institute of Phthisiopulmonology, St. Petersburg, Russia
5 shared publications - Olga Narvskaya
St. Petersburg Pasteur Institute
3 shared publications - Viacheslav Zhuravlev
St. Petersburg Research Institute of Phthisiopulmonology
3 shared publications Соловьева Наталья Сергеевна
ФГБУ «Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии» Минздрава России
2 shared publications
Latest Publications
- Open Access
- 26 February 2026
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 103 (1) , 33-43
Prevalence and genotypic structure of mixed cultures of Mycobacterium tuberculosis among patients with HIV-associated tuberculosis in St. Petersburg
The aim of the study was to assess the frequency of mixed infections caused by several strains (mixed culture) of Mycobacterium tuberculosis among patients with HIV-associated generalized tuberculosis in St. Petersburg, and to conduct a comparative analysis of the genotypic diversity of strains in mixed cultures and among “pure” cultures of the tuberculosis pathogen. Materials and methods. A total of 173 M. tuberculosis isolates obtained from autopsy specimens of 70 patients with HIV-associated generalized tuberculosis between 2012 and 2018 were analyzed. The Beijing genotype and its subtypes were determined using PCR and IS6110-RFLP typing. Non-Beijing isolates were spoligotyped, and their genetic families were identified using the international SITVIT2 database. Genotypic resistance to rifampicin and isoniazid was detected using the Amplitub-MDR-RV test system. Results. Mixed infections were detected in 15 of 70 patients with HIV-associated multidrug-resistant tuberculosis. The same M. tuberculosis genotypes—Beijing, LAM, Ural, Haarlem, and X—were identified in the mixed cultures as in the pure cultures. Beijing strains, primarily subtypes B0/W148 (60%) and CAR (53.3%), were detected in all mixed cultures. The proportions of B0/W148 and LAM strains were significantly higher among mixed cultures (p 0.05). Strains from mixed cultures had more than one mutation in different codons in the rpoB gene. Mixed cultures were more common in patients serving sentences in penal institutions (p = 0.0007). Conclusions. The proportion of mixed infections among patients with HIV-associated tuberculosis was 21.4%; all mixed cultures contained strains of the Beijing genotype. A history of imprisonment was a significant risk factor for developing mixed infections.
- 26 February 2026
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 103 (1) , 33-43
Open AccessPrevalence and genotypic structure of mixed cultures of Mycobacterium tuberculosis among patients with HIV-associated tuberculosis in St. Petersburg
The aim of the study was to assess the frequency of mixed infections caused by several strains (mixed culture) of Mycobacterium tuberculosis among patients with HIV-associated generalized tuberculosis in St. Petersburg, and to conduct a comparative analysis of the genotypic diversity of strains in mixed cultures and among “pure” cultures of the tuberculosis pathogen. Materials and methods. A total of 173 M. tuberculosis isolates obtained from autopsy specimens of 70 patients with HIV-associated generalized tuberculosis between 2012 and 2018 were analyzed. The Beijing genotype and its subtypes were determined using PCR and IS6110-RFLP typing. Non-Beijing isolates were spoligotyped, and their genetic families were identified using the international SITVIT2 database. Genotypic resistance to rifampicin and isoniazid was detected using the Amplitub-MDR-RV test system. Results. Mixed infections were detected in 15 of 70 patients with HIV-associated multidrug-resistant tuberculosis. The same M. tuberculosis genotypes—Beijing, LAM, Ural, Haarlem, and X—were identified in the mixed cultures as in the pure cultures. Beijing strains, primarily subtypes B0/W148 (60%) and CAR (53.3%), were detected in all mixed cultures. The proportions of B0/W148 and LAM strains were significantly higher among mixed cultures (p 0.05). Strains from mixed cultures had more than one mutation in different codons in the rpoB gene. Mixed cultures were more common in patients serving sentences in penal institutions (p = 0.0007). Conclusions. The proportion of mixed infections among patients with HIV-associated tuberculosis was 21.4%; all mixed cultures contained strains of the Beijing genotype. A history of imprisonment was a significant risk factor for developing mixed infections.
- Open Access
- 16 July 2024
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 101 (3) , 342-350
Molecular characteristics of fluoroquinolone-resistant Mycobacterium tuberculosis strains from newly diagnosed tuberculosis patients in the Northwest of Russia
Introduction. Fluoroquinolones remain the key second-line anti-tuberculosis drugs. The aim of the study was the molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis strains from newly diagnosed tuberculosis patients in the Northwest of the Russian Federation. Materials and methods. The retrospective study collection included M. tuberculosis isolates isolated in 2015–2019 from previously untreated tuberculosis patients. Susceptibility to antituberculosis drugs (including the fluoroquinolone ofloxacin) was determined using the BACTEC MGIT960 or absolute concentration method. Mutations in the gyrA gene as a marker of resistance to fluoroquinolones, were detected by real-time PCR. Beijing genotype and its subtypes were detected by PCR and real-time PCR methods. Non-Beijing strains were spoligotyped. Results and discussion. Phenotypic resistance to ofloxacin was detected in 6.7% (40/599) of strains and in 17.4% (40/230) of MDR strains. 34 of 40 (85%) ofloxacin-resistant strains belonged to the Beijing genotype. 18 (45%) strains were assigned to the Russian epidemic subtype Beijing B0/W148 and 12 (30%) to Beijing Central Asian/Russian. The remaining 6 ofloxacin-resistant strains belonged to the Euro-American phylogenetic lineage. Mutations in the gyrA gene were found in 97.5% (39/40) of strains. The most common were mutations in codon 94 (69.2%, 27/39). The Asp94Gly substitution was identified in 57.5% (23/40) of ofloxacin-resistant strains and was dominant among Beijing (19/34) and non-Beijing (4/6) strains. The second most common substitution was Ala90Val (25%, 10/40). More than half of the ofloxacin-resistant strains, Beijing B0/W148 (10/18) and Central Asian/Russian (7/12), carried the Asp94Gly mutation. Conclusion. In the Northwest of Russia in 2016-2019, primary resistance of M. tuberculosis to fluoroquinolones was 6.7% in the total collection and 17.4% of MDR strains, and was mainly caused by the gyrA Asp94Gly and Ala90Val mutations. Beijing B0/W148 genotype was characterized by the largest proportion of fluoroquinolone-resistant strains.
- 16 July 2024
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 101 (3) , 342-350
Open AccessMolecular characteristics of fluoroquinolone-resistant Mycobacterium tuberculosis strains from newly diagnosed tuberculosis patients in the Northwest of Russia
Introduction. Fluoroquinolones remain the key second-line anti-tuberculosis drugs. The aim of the study was the molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis strains from newly diagnosed tuberculosis patients in the Northwest of the Russian Federation. Materials and methods. The retrospective study collection included M. tuberculosis isolates isolated in 2015–2019 from previously untreated tuberculosis patients. Susceptibility to antituberculosis drugs (including the fluoroquinolone ofloxacin) was determined using the BACTEC MGIT960 or absolute concentration method. Mutations in the gyrA gene as a marker of resistance to fluoroquinolones, were detected by real-time PCR. Beijing genotype and its subtypes were detected by PCR and real-time PCR methods. Non-Beijing strains were spoligotyped. Results and discussion. Phenotypic resistance to ofloxacin was detected in 6.7% (40/599) of strains and in 17.4% (40/230) of MDR strains. 34 of 40 (85%) ofloxacin-resistant strains belonged to the Beijing genotype. 18 (45%) strains were assigned to the Russian epidemic subtype Beijing B0/W148 and 12 (30%) to Beijing Central Asian/Russian. The remaining 6 ofloxacin-resistant strains belonged to the Euro-American phylogenetic lineage. Mutations in the gyrA gene were found in 97.5% (39/40) of strains. The most common were mutations in codon 94 (69.2%, 27/39). The Asp94Gly substitution was identified in 57.5% (23/40) of ofloxacin-resistant strains and was dominant among Beijing (19/34) and non-Beijing (4/6) strains. The second most common substitution was Ala90Val (25%, 10/40). More than half of the ofloxacin-resistant strains, Beijing B0/W148 (10/18) and Central Asian/Russian (7/12), carried the Asp94Gly mutation. Conclusion. In the Northwest of Russia in 2016-2019, primary resistance of M. tuberculosis to fluoroquinolones was 6.7% in the total collection and 17.4% of MDR strains, and was mainly caused by the gyrA Asp94Gly and Ala90Val mutations. Beijing B0/W148 genotype was characterized by the largest proportion of fluoroquinolone-resistant strains.
- Open Access
- 22 November 2023
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 100 (5) , 338-345
Molecular epidemiological monitoring of the tuberculosis pathogen in the Arkhangelsk region
Introduction. Against the background of improvement of the main epidemiological indicators (morbidity and mortality) for tuberculosis in the Arkhangelsk region, the proportion of newly diagnosed tuberculosis patients with multidrug-resistant pathogen (MDR-TB) increased from 18.7% in 2002 to 33.8% in 2018. The purpose of this study was the genotypic characterization of Mycobacterium tuberculosis strains obtained from newly diagnosed tuberculosis patients in the Arkhangelsk region in 2018. Materials and methods. 89 M. tuberculosis strains isolated in 2018 from newly diagnosed tuberculosis patients were studied. Beijing genotype, its clusters B0/W148 and Central Asian/Russian were determined by PCR detection of the specific markers: IS6110 insertions in the dnaA-dnaN region, mutations in codons 48 of the mutT4 gene (CGG GGG) and 58 of the mutT2 gene (GGA CGA), IS6110 insertions in the Rv2664 region-Rv2665 and Rv1359-Rv1360, substitutions G A in the sigE gene. Non-Beijing strains were spoligotyped. Results. Drug resistance was detected in 41.6% (37/89), MDR — in 33.7% of strains. In 90% (27/30) of MDR strains, resistance to rifampicin and isoniazid was due to rpoB Ser531Leu and katG Ser315Thr mutations. Following M. tuberculosis genotypes were identified: Beijing (67.4%), T (14.6%), Ural (4.5%), Haarlem (4.5%), LAM (2.3%) and CAS1-Delhi (1.1%). Among the Beijing strains, clusters Central-Asian/Russian (60%; 36/60) and B0/W148 (30%; 18/60) prevailed. The majority of MDR strains belonged to the Beijing family (93.3%; 28/30), of which 64.3% (18/28) and 21.4% (6/28) belonged to clusters B0/W148 and Central-Asian/Russian, respectively. Conclusion. In heterogeneous population of the causative agent of tuberculosis in the Arkhangelsk region, the most common strains were those of the Beijing genotype; in 2018 its share increased to 67.4% (40.4% in 1998–1999). Among MDR strains, the proportion of Beijing reached 93.3%, of which more than half (64.3%) belonged to the epidemiologically and clinically significant in Russia cluster B0/W148.
- 22 November 2023
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 100 (5) , 338-345
Open AccessMolecular epidemiological monitoring of the tuberculosis pathogen in the Arkhangelsk region
Introduction. Against the background of improvement of the main epidemiological indicators (morbidity and mortality) for tuberculosis in the Arkhangelsk region, the proportion of newly diagnosed tuberculosis patients with multidrug-resistant pathogen (MDR-TB) increased from 18.7% in 2002 to 33.8% in 2018. The purpose of this study was the genotypic characterization of Mycobacterium tuberculosis strains obtained from newly diagnosed tuberculosis patients in the Arkhangelsk region in 2018. Materials and methods. 89 M. tuberculosis strains isolated in 2018 from newly diagnosed tuberculosis patients were studied. Beijing genotype, its clusters B0/W148 and Central Asian/Russian were determined by PCR detection of the specific markers: IS6110 insertions in the dnaA-dnaN region, mutations in codons 48 of the mutT4 gene (CGG GGG) and 58 of the mutT2 gene (GGA CGA), IS6110 insertions in the Rv2664 region-Rv2665 and Rv1359-Rv1360, substitutions G A in the sigE gene. Non-Beijing strains were spoligotyped. Results. Drug resistance was detected in 41.6% (37/89), MDR — in 33.7% of strains. In 90% (27/30) of MDR strains, resistance to rifampicin and isoniazid was due to rpoB Ser531Leu and katG Ser315Thr mutations. Following M. tuberculosis genotypes were identified: Beijing (67.4%), T (14.6%), Ural (4.5%), Haarlem (4.5%), LAM (2.3%) and CAS1-Delhi (1.1%). Among the Beijing strains, clusters Central-Asian/Russian (60%; 36/60) and B0/W148 (30%; 18/60) prevailed. The majority of MDR strains belonged to the Beijing family (93.3%; 28/30), of which 64.3% (18/28) and 21.4% (6/28) belonged to clusters B0/W148 and Central-Asian/Russian, respectively. Conclusion. In heterogeneous population of the causative agent of tuberculosis in the Arkhangelsk region, the most common strains were those of the Beijing genotype; in 2018 its share increased to 67.4% (40.4% in 1998–1999). Among MDR strains, the proportion of Beijing reached 93.3%, of which more than half (64.3%) belonged to the epidemiologically and clinically significant in Russia cluster B0/W148.
- 1 June 2022
- Published by Allerton Press in Molecular Genetics, Microbiology and Virology
- Vol. 37 (2) , 71-77
Molecular-Genetic Monitoring of the Mycobacterium tuberculosis Population in Murmansk Oblast
In Murmansk oblast, the first molecular-genetic studies of circulating strains of Mycobacterium tuberculosis were carried out during the years of an increa
- 1 June 2022
- Published by Allerton Press in Molecular Genetics, Microbiology and Virology
- Vol. 37 (2) , 71-77
Molecular-Genetic Monitoring of the Mycobacterium tuberculosis Population in Murmansk Oblast
In Murmansk oblast, the first molecular-genetic studies of circulating strains of Mycobacterium tuberculosis were carried out during the years of an increa
- Open Access
- 30 December 2018
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 8 (4) , 585
POPULATION STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS IN RUSSIAN REGIONS BORDERING EU COUNTRIES
POPULATION STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS IN RUSSIAN REGIONS BORDERING EU COUNTRIES
- 30 December 2018
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 8 (4) , 585
Open AccessPOPULATION STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS IN RUSSIAN REGIONS BORDERING EU COUNTRIES
POPULATION STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS IN RUSSIAN REGIONS BORDERING EU COUNTRIES